Macular edema consists of intra-or subretinal fluid accumulation in the macular region. It
occurs during the course of numerous retinal disorders and can cause severe impairment of …

Newer anticancer drugs have revolutionized cancer treatment in the last decade, but
conventional chemotherapy still occupies a central position in many cancers, with …

Background Melanoma is one of the most aggressive skin cancers. Recently, selective MEK
inhibitors have shown efficacy in patients with advanced BRAF-and NRAS-mutant …

Purpose: To review reported retinal side effects from current cancer therapy drugs. Methods:
Retinal toxicities from ophthalmologic or oncologic case reports, case series, and clinical …

Macular edema constitutes a serious pathologic entity of ophthalmology resulting in vision
loss with a remarkable impact on the quality of life of patients. It is the final common pathway …

The treatment of advanced disease (stage IIIb and IV) of non-small cell lung cancer
(NSCLC) is based on systemic treatment with platinum-based chemotherapy or biological …

Paclitaxel and nanoparticle albumin-bound paclitaxel are known to cause adverse events of
eye disorders, such as cystoid macular edema. However, at present, the risk factors remain …

Interventions: Paclitaxel was discontinued and supportive treatment with pentoxifylline was
given. Outcomes: The OCT showed bilateral cystoid macular edema. Impaired filling of …

Purpose To evaluate the characteristics of macular retinal and subfoveal choroidal changes
in patients already on taxane-based therapy by the help of spectral domain optical …

Purpose To report the first case of cystoid macular edema (CME) induced by nabpaclitaxel
treated with intravitreal dexamethasone implant. Observations A 67 year-old man diagnosed …